IDH1 and neoplasm: Among 35 patients with WHO grade III gliomas who were operated upon using 5-ALA fluorescence-guided surgery, IDH1 mutations were observed in 24 and intraoperative fluorescence was observed in tumor tissues of 19 patients (Table 1).